Unknown

Dataset Information

0

CHK1 Inhibitor Blocks Phosphorylation of FAM122A and Promotes Replication Stress.


ABSTRACT: While effective anti-cancer drugs targeting the CHK1 kinase are advancing in the clinic, drug resistance is rapidly emerging. Here, we demonstrate that CRISPR-mediated knockout of the little-known gene FAM122A/PABIR1 confers cellular resistance to CHK1 inhibitors (CHK1is) and cross-resistance to ATR inhibitors. Knockout of FAM122A results in activation of PP2A-B55α, a phosphatase that dephosphorylates the WEE1 protein and rescues WEE1 from ubiquitin-mediated degradation. The resulting increase in WEE1 protein expression reduces replication stress, activates the G2/M checkpoint, and confers cellular resistance to CHK1is. Interestingly, in tumor cells with oncogene-driven replication stress, CHK1 can directly phosphorylate FAM122A, leading to activation of the PP2A-B55α phosphatase and increased WEE1 expression. A combination of a CHK1i plus a WEE1 inhibitor can overcome CHK1i resistance of these tumor cells, thereby enhancing anti-cancer activity. The FAM122A expression level in a tumor cell can serve as a useful biomarker for predicting CHK1i sensitivity or resistance.

SUBMITTER: Li F 

PROVIDER: S-EPMC7761918 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

2021-01-01 | GSE158338 | GEO
| PRJNA664943 | ENA
| S-EPMC7781613 | biostudies-literature
| S-EPMC8345057 | biostudies-literature
2022-02-10 | PXD011328 | Pride
| S-EPMC2941317 | biostudies-literature
| S-EPMC5085184 | biostudies-literature
| S-EPMC4787776 | biostudies-literature
| S-EPMC3963179 | biostudies-literature